Literature DB >> 11658032

A review of patient outcomes in pharmacological studies from the psychiatric literature, 1966-1993.

Adil E Shamoo, Dianne N Irving, Patricia Langenberg.   

Abstract

Entities:  

Keywords:  Biomedical and Behavioral Research; Empirical Approach; Mental Health Therapies

Mesh：

Substances：

Year:  1997        PMID： 11658032     DOI： 10.1007/s11948-997-0043-1

Source DB:  PubMed          Journal:  Sci Eng Ethics        ISSN： 1353-3452            Impact factor:   3.525


× No keyword cloud information.
  34 in total

1.  Consent to research with impaired human subjects: a trial policy for the intramural programs of the National Institutes of Health.

Authors:  John C Fletcher; F William Dommel; Daniel D Cowell
Journal:  IRB       Date:  1985 Nov-Dec

Review 2.  Schizophrenia as a progressive disorder: relations to EEG, CT, neuropathological and other evidence.

Authors:  R Miller
Journal:  Prog Neurobiol       Date:  1989       Impact factor: 11.685

Review 3.  Ethical concerns about relapse studies.

Authors:  A E Shamoo; T J Keay
Journal:  Camb Q Healthc Ethics       Date:  1996       Impact factor: 1.284

Review 4.  Neuroleptics and the natural course of schizophrenia.

Authors:  R J Wyatt
Journal:  Schizophr Bull       Date:  1991       Impact factor: 9.306

Review 5.  The social value of fluphenazine decanoate.

Authors:  B Stevens
Journal:  Acta Psychiatr Belg       Date:  1976 Sep-Oct

6.  Double-blind placebo substitution: withdrawal of fluphenazine decanoate in schizophrenic patients.

Authors:  O A Odejide; A F Aderounmu
Journal:  J Clin Psychiatry       Date:  1982-05       Impact factor: 4.384

7.  Our responsibilities toward persons with mental illness as human subjects in research.

Authors:  Adil E Shamoo
Journal:  J Calif Alliance Ment Ill       Date:  1994

8.  The duration of maintenance therapy in chronic schizophrenia.

Authors:  D A Johnson
Journal:  Acta Psychiatr Scand       Date:  1976-04       Impact factor: 6.392

9.  A depot neuroleptic withdrawal study. A controlled study of the clinical effects of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients.

Authors:  B Wistedt
Journal:  Acta Psychiatr Scand       Date:  1981-07       Impact factor: 6.392

10.  Do schizophrenics well adapted in the community need neuroleptics? A depot neuroleptic withdrawal study.

Authors:  S J Dencker; M Lepp; U Malm
Journal:  Acta Psychiatr Scand Suppl       Date:  1980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.